165 related articles for article (PubMed ID: 22905924)
1. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to Ewing's sarcoma.
Yang S; Wang C; Zhou Y; Sun G; Zhu D; Gao S
Genet Test Mol Biomarkers; 2012 Oct; 16(10):1236-40. PubMed ID: 22905924
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T-lymphocyte antigen-4 genetic variants and risk of Ewing's sarcoma.
Feng D; Yang X; Li S; Liu T; Wu Z; Song Y; Wang J; Gao W; Huang Q; Huang W; Zheng W; Xiao J
Genet Test Mol Biomarkers; 2013 Jun; 17(6):458-63. PubMed ID: 23480667
[TBL] [Abstract][Full Text] [Related]
3. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T-lymphocyte antigen-4 +49G/A polymorphism is associated with increased risk of osteosarcoma.
Wang W; Wang J; Song H; Liu J; Song B; Cao X
Genet Test Mol Biomarkers; 2011; 15(7-8):503-6. PubMed ID: 21453059
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W
DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409
[TBL] [Abstract][Full Text] [Related]
6. CD86 +1057G/A polymorphism and susceptibility to Ewing's sarcoma: a case-control study.
Wang J; Zhou Y; Feng D; Yang H; Li F; Cao Q; Wang A; Xing F
DNA Cell Biol; 2012 Apr; 31(4):537-40. PubMed ID: 21870962
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4 exon 1 +49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients.
Duan S; Zhang G; Han Q; Li Z; Liu Z; Chen J; Lv Y; Li N; Wang Y; Li M; Lou S; Yang M; Zhu Q; Xing F
Mol Biol Rep; 2011 Nov; 38(8):5125-32. PubMed ID: 21161390
[TBL] [Abstract][Full Text] [Related]
8. Significant association between cytotoxic T lymphocyte antigen 4 +49G>A polymorphism and risk of malignant bone tumors.
Yu F; Miao J
Tumour Biol; 2013 Dec; 34(6):3371-5. PubMed ID: 23900675
[TBL] [Abstract][Full Text] [Related]
9. Association between CTLA-4 gene polymorphism and ankylosing spondylitis: a case-control study.
Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
Int J Clin Exp Pathol; 2015; 8(6):7421-5. PubMed ID: 26261646
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever.
Gunesacar R; Erken E; Dinkci S
Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220
[TBL] [Abstract][Full Text] [Related]
11. CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis.
Song B; Liu Y; Liu J; Song X; Wang Z; Wang M; Zhu Y; Han J
Respiration; 2011; 82(5):439-44. PubMed ID: 21832820
[TBL] [Abstract][Full Text] [Related]
12. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T-lymphocyte antigen-4 +49G/A polymorphism and susceptibility to pancreatic cancer.
Lang C; Chen L; Li S
DNA Cell Biol; 2012 May; 31(5):683-7. PubMed ID: 22011251
[TBL] [Abstract][Full Text] [Related]
14. Association of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians.
Benmansour J; Stayoussef M; Al-Jenaidi FA; Rajab MH; Rayana CB; Said HB; Mahjoub T; Almawi WY
Clin Vaccine Immunol; 2010 Sep; 17(9):1473-7. PubMed ID: 20610662
[TBL] [Abstract][Full Text] [Related]
15. Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves' disease in Thai population.
Kimkong I; Nakkuntod J; Sae-Ngow S; Snabboon T; Avihingsanon Y; Hirankarn N
Asian Pac J Allergy Immunol; 2011 Sep; 29(3):229-35. PubMed ID: 22053592
[TBL] [Abstract][Full Text] [Related]
16. The association of cytotoxic T-lymphocyte antigen-4 + 49A/G and CT60 polymorphisms with type 1 diabetes and latent autoimmune diabetes in Chinese adults.
Jin P; Xiang B; Huang G; Zhou Z
J Endocrinol Invest; 2015 Feb; 38(2):149-54. PubMed ID: 25185645
[TBL] [Abstract][Full Text] [Related]
17. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
[TBL] [Abstract][Full Text] [Related]
18. Association of the CTLA-4 +49A/G polymorphism with rheumatoid arthritis in Chinese Han population.
Tang MJ; Zhou ZB
Mol Biol Rep; 2013 Mar; 40(3):2627-31. PubMed ID: 23264071
[TBL] [Abstract][Full Text] [Related]
19. Association of Cytotoxic T Lymphocyte Antigen-4 Gene Polymorphisms with Psoriasis Vulgaris: A Case-Control Study in Turkish Population.
Dursun HG; Yılmaz HO; Dursun R; Kulaksızoğlu S
J Immunol Res; 2018; 2018():1643906. PubMed ID: 29850619
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers.
Hadinia A; Hossieni SV; Erfani N; Saberi-Firozi M; Fattahi MJ; Ghaderi A
J Gastroenterol Hepatol; 2007 Dec; 22(12):2283-7. PubMed ID: 18031393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
